Merck’s antiviral pill, recently approved for use in the UK, has no link to ivermectin

The United Kingdom has become the first country in the world to approve molnupiravir, an antiviral pill developed by Merck to treat COVID-19. Pfizer is also testing antiviral drugs to prevent COVID-19.

The UK government said earlier this week it had secured deals for two COVID-19 antiviral drugs, one developed by Merck and the other by Pfizer, which it said could be used to treat patients by the end of the year if regulatory approval is granted.

Britain is the first country to approve Merck’s Covid-19 antiviral pill, with the nation’s drug regulator describing the treatment as safe and effective

What people are saying?

Stuart Pureblood. I’ll still take ivermectin, it’s cheaper, proven to work and is not developed by two blood thirsty pharmaceutical companies that are solely interested in profit.

The Jon Donnis It’s definitely nothing like Ivermectin, honestly, we would never lie to you would we, we have been totally honest from day one, and the idea that there is this cheap drug out there that cures Covid and we knew a year ago is pure conspiracy.